
The little known warning sign that could mean you are MORE at risk of developing dementia
Dr. Kaete Archer - an ear, nose and throat doctor - revealed that experiencing middle-aged hearing loss could put you at a higher risk of developing the disease in comparison to those with healthy hearing.
'New research has shown that even early, mild hearing loss is a significant risk factor for dementia,' she explained in a recent video posted to TikTok.
The expert then explained that untreated midlife hearing loss is responsible for seven percent of cases of Alzheimer's dementia globally.
'What if the first sign of cognitive decline wasn't memory loss, but rather trouble hearing?' the doctor questioned.
She continued, saying hearing loss in middle aged people (between 40 to 60 years old) is often overlooked, but warned that anyone who experiences this should be extra careful.
Archer detailed how hearing loss and dementia are related, explaining the brain is constantly receiving inputs from the world and, as our hearing declines, people's ability to process and receive those sensory inputs also declines.
'In response, our ability to interact back with the world declines and this has a significant negative impact and consequence on our brain and health function,' she said.
The doctor quipped: 'It's not very sexy to tell someone they need a hearing aid, but what is very sexy is doing everything in your power to protect your brain health.'
She urged anyone that is concerned about their hearing to make an appointment with an audiologist or ENT (ear, nose and throat doctor).
Researchers estimated that 42 percent of Americans over age 55 will eventually develop dementia, as per the National Institute of Health.
Shruthi Raghavendra, an audio research scientist at Harman International, told the Daily Mail that hearing loss is often overlooked as a modifiable risk factor for dementia, but growing research highlights its role in accelerating cognitive decline, social isolation, and neural atrophy.
'People with dementia may struggle to process auditory information, which can appear similar to hearing loss,' she explained.
She added: 'Conversely, hearing loss can mimic or accelerate cognitive decline, making it harder to diagnose dementia accurately.'
She explained there are three main mechanisms of the scientific link between hearing loss and dementia.
The first was cognitive load theory, meaning the brain works harder to decode degraded auditory input from the ears.
'This "listening effort" diverts cognitive resources from memory, reasoning, or attention,' she explained. 'Over time, this constant strain may increase vulnerability to cognitive decline.'
'The second is auditory deprivation, as hearing loss reduces input to the auditory cortex, the part of the brain that processes audio,' Raghavendra said.
She explained the lack of stimulation can lead to atrophy in brain regions, including those involved in speech processing and memory (e.g. temporal lobes, hippocampus).
The third was social isolation, as hearing loss can lead to withdrawal from conversations and social activities, which she branded as a 'strong, independent risk factor for dementia.'
Scientists have pinpointed subtle, telltale signs of the memory-robbing disease that can occur up to twenty years before the onslaught of classic symptoms strike.
Problems with spatial awareness, like difficulty reading the sat nav or standing too close to other people, are thought to be the first signs of a future dementia diagnosis.
Experts say these troubles often begin prior to the telltale brain damage appearing on scans.
That's because, according to researchers from the Allen Institute for Brain Science in Seattle, the disease develops in two distinct phases, known as 'epochs.'
The first so-called 'stealth' phase, which can begin decades before symptoms become obvious, involves damage to just a few vulnerable cells in the brain.
And this typically happens in the part of the brain that's important for spatial navigation, Professor Michael Hornberger, dementia expert from the University of East Anglia, explained in a new report about the US research.
The second phase, sees a build up of the proteins tau and amyloid in the brain. Whilst most aging brains will have some level of both these proteins, a significant clump of them can for plaques and tangle — and this is thought to be behind dementia symptoms.
This is when telltale signs of cognitive collapse that we commonly associate with dementia — including memory loss, language difficulties and problems with thinking and reasoning — appear.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
an hour ago
- Telegraph
The militant strike ringleader who now controls the BMA
The militant Corbynista who helped inspire the first doctors' strikes in 40 years is now in charge of the British Medical Association (BMA). Dr Thomas Dolphin, a consultant anaesthetist in London, beat four other candidates to become chairman of the BMA council last month and will now lead it for at least three years in what is already looking like a painful tenure for Wes Streeting. Ironically, had things gone the way Dr Dolphin had planned, he would be in the House of Commons alongside the Health Secretary. But the Labour Party did not shortlist him to run as an MP at last year's general election, and now he faces them instead as agitator-in-chief. The 47-year-old has a base salary in excess of £126,000 and has spent the past 20 years building on his political ambitions, playing a pivotal role in turning the union into the militant group of strikers that it is today. He is part of a group of doctors who have 'ideologically captured' the BMA, according to insiders, and been labelled by critics as 'Trots' – a reference to the hard-Left ideals of Leon Trotsky, the Marxist revolutionary. Last year, Dr Dolphin was responsible for putting forward a motion – that was passed without debate – to reject the independent Cass review into children's transgender healthcare, which had called on the NHS to stop prescribing puberty blockers to children. More than 1,000 union members signed an open letter in revolt, and around 200 medics quit as a result, insiders claim. An activist during the days of Jeremy Corbyn, he campaigned alongside John McDonnell, the former shadow chancellor and socialist, and has been the election agent for Dawn Butler, the London MP for Brent East, in the last three elections. His rise to the top of the BMA has coincided with increasing levels of political activism and dissonance among members. He has been a critic of the Government and an outspoken member of the union since the days of Tony Blair – when the BMA says doctors were last paid fairly. In 2007, a young Dr Dolphin championed the BMA's calls for Patricia Hewitt, the former health secretary, to resign over a chaotic online application system for junior doctors that resulted in medics not being offered job interviews. He rose to become chairman of the union's junior doctors' committee and in 2012, supported doctors' first industrial action since the 1970s over pension reforms. He has been a hardline union activist and advocate of striking as a means to achieve results ever since. He made media appearances backing a series of junior doctor walkouts in 2016, despite by this point being a consultant and member of the BMA's consultant committee and council. In 2023, he fronted the senior doctors' own campaign for pay rises, claiming consultants had seen real-terms cuts to pay of 35 per cent since 2010, as they timed strikes to coincide with the junior doctors' walkouts and the Conservative Party conference. Although now he says, the union is 'non-partisan' and he is in a 'non-partisan role'. 'As in, I don't have any political affiliation as chair of council,' he told the Guardian last week. He also warned that the 29 per cent rise the junior doctors – now called resident doctors – are demanding is 'non-negotiable' and could mean strikes go on for years. Mr Streeting has also said that any increase on the 5.4 per cent pay award for 2025-26 was 'off the table', leaving both parties at an impasse. The Health Secretary said it was 'completely unreasonable' that the doctors would strike having received a 28.9 per cent salary uplift in three years. He is set to meet with the BMA's resident doctors' committee this week to see if there is a way to 'avert' the five-day walkout, which begins at 7am on 25 July. The rise of Dr Dolphin and like-minded political activists has coincided with the union increasingly alienating itself from the public and other doctors. Recent polling shows just one in five Britons strongly back the resident doctors' strikes, while senior medics have criticised the walkouts and even quit the union as a result. Its annual general meeting has attracted criticism for its increasing focus on political issues such as Palestine and Israel, its rejection of the Supreme Court's ruling on what a biological woman is and how single-sex care should be delivered, as well as the anti-Cass motion put forward by Dr Dolphin. The new chairman has also already written to Yvette Cooper, the Home Secretary, to criticise the Government's plans to 'restore control to our borders' outlined in the Immigration White Paper. He said plans to increase the years that people, including doctors, must spend in the UK to obtain settlement status from five to 10 years would 'create unnecessary stress and uncertainty', and that the BMA was also 'deeply concerned' about introducing 'stricter English language requirements for adult dependants including spouses'. On taking up the role of chairman last month, he told the BMA's 190,000 members: 'The fight to restore doctors' pay and pensions continues, with colleagues across the country furious that the promised 'journey' towards pay restoration that we were promised has already come to a grinding halt.' With consultants also holding an 'indicative ballot' on industrial action, the upcoming strikes look set to be just the first under Dr Dolphin's reign.


Daily Mail
an hour ago
- Daily Mail
Eating just 4 ounces of common food each week cuts Alzheimer's risk by 40%
Older adults who eat two eggs a week may be less likely to develop Alzheimer's disease, a new study claims. Researchers from Boston, Washington DC and Chicago found that the presence of several nutrients, particularly choline in the breakfast staple can help lower the risk of the progressive disease. Choline is an essential nutrient for liver development, healthy brain development, muscle movement, maintaining nervous system health and metabolism. While previous research has suggested that eating eggs may support cognitive performance, this new study has been able to find that the choline in eggs can reduce the risk of Alzheimer's-related dementia by 40 percent. Alzheimer's disease is believed to be caused by the development of plaques created by protein cells in the brain, which damage and kill cells. But now, scientists believe that choline can protect the brain cells from decay and damage, therefore reducing a person's risk of developing the disease. Alzheimer's disease is the most common form of dementia and primarily affects people over the age of 65. More than 7.2 million adults among that age bracket in the US are currently living with the condition, and over 100,000 die from it each year. The Alzheimer's Association warns that nearly 13 million Americans may be affected by 2050. While there is no clear cause of the disease, experts believe that cases of Alzheimer's are set to increase in the future due to genetic mutations and lifestyle choices, such as physical inactivity, unhealthy diet and social isolation. To find the link between consuming eggs and the potential decrease in the risk of developing Alzheimer's, the researchers analyzed data from 1,024 dementia-free people. The participants were asked to fill in a well-known food frequency questionnaire developed at Harvard University that captures their typical diet over the previous year, including how often they ate eggs. Once completed, they were followed by the researchers for nearly seven years and underwent yearly assessments for signs of Alzheimer's dementia. The scientists divided these participants into four groups based on how often they consumed eggs: less than once per month, one to three times per month, once per week and two or more times per week. The volunteer's answers as well as the data from their cognitive tests were then evaluated using various statistical models. Along with the 1,024 living participants, another 578 participants donated their brains for research after death. These brain samples allowed the scientists to assess whether egg intake was related to the presence of dementia-related markers. It remains unclear if all the deceased participants were suffering from dementia prior to their death. Results showed that people who ate eggs at least once a week had a lower rate of clinical Alzheimer's diagnosis than those who ate them rarely. Specifically, those who ate eggs once-a-week or two-or-more-times-per-week groups had about half the risk of developing Alzheimer's dementia compared to those who consumed eggs less than once a month. Participants who ate eggs more frequently also had significantly higher average choline levels over time. While this observational study did not expand on how choline can decrease the risk of Alzheimer's disease by up to 40 percent, the scientists theorized that it's overall protective effect may play a critical role in protecting brain cells from damage. Choline is a nutrient essential for producing acetylcholine, a neurotransmitter that maintains the brain's memory and learning capacity. It also plays a significant role in maintaining and protecting the structure of cell membranes in the brain. Previous studies have shown that low choline levels in the blood are associated with increased levels of amyloid plaques and tau tangles in the brain - both of which are the main culprits in the development of the Alzheimer's. The plaques and tangles form when amyloid proteins misfold and stick together, forming sticky clumps (plaques) and when tau proteins twist and get tied up (tangles). These toxic buildups block brain cells, or neurons, from sending signals properly. Over time, this can impair brain functioning and lead to memory and muscle decline. If it persists, this disruption can cause permanent damage in the brain that leads to Alzheimer's disease. As the disease progresses, patients may lose the ability to speak, care for themselves or even respond to the world around them. However, the researchers believe that regularly consuming eggs can maintain choline levels in the body, which in turn can help maintain brain cell health and prevent the formation of amyloid plaques and tau tangles. Even though the liver produces choline in small amounts, experts say that it is necessary to consume food items such as egg yolks, fish, soybeans and legumes to maintain the required levels of the nutrient in the body. According to the National Institute of Health, adult women (above the age of 19) need to consume about 425 milligrams of choline per day while adult men need to consume 550 mg of the nutrient every day. One large hard boiled egg has about 147 mg of choline while half a cup of roasted soybeans contain about 107 mg of the nutrient. On the other hand, three ounces of pan-fried beef liver contains about 356 mg of choline while three ounces of cooked fresh cod merely has 71 mg of the nutrient.


Reuters
an hour ago
- Reuters
Becton to merge unit with Waters in $17.5 billion deal
July 14 (Reuters) - Lab equipment maker Waters Corp (WAT.N), opens new tab will merge with rival Becton, Dickinson and Company's (BDX.N), opens new tab Biosciences & Diagnostic Solutions unit in a $17.5 billion deal, the companies said, creating a larger entity focused on high-volume medical testing. The deal announced on Monday is structured as a so-called Reverse Morris Trust, which allows a company to avoid a big tax bill by spinning off a unit that it wants to divest while simultaneously merging it with another company. The eye-popping deal value signifies the amount of stock that BD shareholders will have in the combined company - about 39.2% - and the $4 billion cash distribution that BD will receive at closing. Becton's biosciences and diagnostic solutions unit makes products used to detect infectious diseases and cancers. The company has been looking to divest the unit to deepen focus on its core business of medical devices. Funding for life sciences and microbiology research has been under pressure in recent years, impacting the performance of BD's biosciences business. Meanwhile, sale of medical devices remained robust post pandemic due to the increased demand for outpatient and other surgeries. The merger doubles Waters' addressable market to $40 billion, enhances recurring revenue streams and accelerates expansion into areas such as bioseparations, bioanalytical characterization and multiplex diagnostics, Waters CEO Udit Batra said. The market reaction, however, was opposite, with Waters' shares falling 5.3% premarket following the announcement. Becton's stock was marginally down. Leerink analysts said investors will likely not view the deal as attractive in the near term, given the higher exposure to microbiology amid recent funding cuts. As part of the deal, which is expected to close in the first quarter of 2026, Waters will assume about $4 billion in incremental debt.